APA (7th ed.) Citation

Yozgat, Z., Isik, M. U., & Sabaner, M. C. One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Yozgat, Zubeyir, Mehmed Ugur Isik, and Mehmet Cem Sabaner. One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study. Adis, Springer Healthcare.

MLA (9th ed.) Citation

Yozgat, Zubeyir, et al. One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study. Adis, Springer Healthcare.